Neurogene Inc. (NGNE) SEC filings
NGNE SEC filings moved a median of +0.51% by the close. NGNE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NGNE overview →
70 measured NGNE SEC filing events.
Where these NGNE SEC filings landedvs 67 measured NGNE SEC filing reactions
| Middle 50% of NGNE SEC filing reactions | -1.60% to +3.72% |
|---|---|
| Median reaction (to close) | +0.51% |
| Measured reactions | 67 |
Point-in-time · zero look-ahead
Half of the 67 NGNE SEC filing events with a measured close landed between -1.60% and +3.72%; 60% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Neurogene Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.33% | +1.07% | |
| Form 8-K Neurogene Inc. For: Aug 11 | SEC filing · Form 8-K | -3.29% | -1.08% | |
| Form 8-K Neurogene Inc. For: Jun 30 | SEC filing · Form 8-K | +0.53% | +3.79% | |
| Form 8-K Neurogene Inc. For: Jun 29 | SEC filing · Form 8-K | +0.83% | -0.19% | |
| Form 8-K Neurogene Inc. For: Jun 08 | SEC filing · Form 8-K | -0.50% | +5.54% | |
| Form 8-K Neurogene Inc. For: Jun 03 | SEC filing · Form 8-K | -2.37% | -3.60% | |
| Form 10-Q Neurogene Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.01% | +3.42% | |
| Form 8-K Neurogene Inc. For: May 12 | SEC filing · Form 8-K | +2.01% | +3.42% | |
| Form 8-K Neurogene Inc. For: Apr 20 | SEC filing · Form 8-K | -0.40% | +0.51% | |
| Form ARS Neurogene Inc. For: Dec 31 | SEC filing · Form ARS | +3.02% | +6.34% | |
| Form DEF 14A Neurogene Inc. For: Jun 03 | SEC filing · Form DEF | +3.02% | +6.34% | |
| Form DEFA14A Neurogene Inc. | SEC filing · Form DEFA14A | +3.02% | +6.34% | |
| Form 10-K Neurogene Inc. For: Dec 31 | SEC filing · Form 10-K | +1.18% | +3.72% | |
| Form 8-K Neurogene Inc. For: Mar 24 | SEC filing · Form 8-K | -0.21% | +8.29% | |
| Form S-8 Neurogene Inc. | SEC filing · Form S-8 | +1.18% | +3.72% | |
| Form 8-K Neurogene Inc. For: Feb 26 | SEC filing · Form 8-K | -1.05% | +2.31% | |
| Form 8-K Neurogene Inc. For: Jan 12 | SEC filing · Form 8-K | -3.83% | -4.11% | |
| Form 8-K Neurogene Inc. For: Nov 12 | SEC filing · Form 8-K | -2.05% | — | |
| Form 8-K Neurogene Inc. For: Nov 06 | SEC filing · Form 8-K | +0.02% | -3.89% | |
| Form 8-K Neurogene Inc. For: Oct 09 | SEC filing · Form 8-K | +1.88% | +18.56% | |
| Form 10-Q Neurogene Inc. For: Jun 30 | SEC filing · Form 10-Q | -4.01% | — | |
| Form 8-K Neurogene Inc. For: Aug 11 | SEC filing · Form 8-K | -4.01% | — | |
| Form 8-K Neurogene Inc. For: Jun 30 | SEC filing · Form 8-K | -3.47% | +23.81% | |
| Form 8-K Neurogene Inc. For: Jun 12 | SEC filing · Form 8-K | +1.64% | +1.28% | |
| Form 8-K Neurogene Inc. For: Jun 09 | SEC filing · Form 8-K | +0.00% | -8.71% | |
| Form 10-Q Neurogene Inc. For: Mar 31 | SEC filing · Form 10-Q | +3.00% | +0.55% | |
| Form 8-K Neurogene Inc. For: May 09 | SEC filing · Form 8-K | +3.00% | +0.55% | |
| Form ARS Neurogene Inc. For: Dec 31 | SEC filing · Form ARS | — | +2.73% | |
| Form DEF 14A Neurogene Inc. For: Apr 25 | SEC filing · Form DEF | -0.27% | +2.46% | |
| Form DEFA14A Neurogene Inc. | SEC filing · Form DEFA14A | -0.27% | +2.46% | |
| Form 8-K Neurogene Inc. For: Apr 14 | SEC filing · Form 8-K | +2.55% | +5.18% | |
| Form EFFECT Neurogene Inc. | SEC filing · Form EFFECT | -0.36% | -5.81% | |
| Form EFFECT Neurogene Inc. | SEC filing · Form EFFECT | -2.25% | -15.21% | |
| Form 10-K Neurogene Inc. For: Dec 31 | SEC filing · Form 10-K | +4.45% | +0.21% | |
| Form 8-K Neurogene Inc. For: Mar 24 | SEC filing · Form 8-K | +4.45% | +0.21% | |
| Form POS AM Neurogene Inc. | SEC filing · Form POS | +4.45% | +0.21% | |
| Form S-3 Neurogene Inc. | SEC filing · Form S-3 | +4.45% | +0.21% | |
| Form S-8 Neurogene Inc. | SEC filing · Form S-8 | +4.45% | +0.21% | |
| Form 8-K Neurogene Inc. For: Jan 13 | SEC filing · Form 8-K | +0.29% | -1.52% | |
| Form EFFECT Neurogene Inc. | SEC filing · Form EFFECT | +2.06% | -4.12% | |
| Form S-1 Neurogene Inc. | SEC filing · Form S-1 | -1.90% | -7.72% | |
| Form 8-K Neurogene Inc. For: Nov 20 | SEC filing · Form 8-K | +0.78% | +31.14% | |
| Form 10-Q Neurogene Inc. For: Sep 30 | SEC filing · Form 10-Q | -13.97% | -17.56% | |
| Form 8-K Neurogene Inc. For: Nov 18 | SEC filing · Form 8-K | -8.90% | -10.88% | |
| Form NT 10-Q Neurogene Inc. For: Sep 30 | SEC filing · Form NT | -1.13% | -11.13% | |
| Form 8-K Neurogene Inc. For: Nov 11 | SEC filing · Form 8-K | -3.78% | -8.38% | |
| Form 8-K Neurogene Inc. For: Nov 04 | SEC filing · Form 8-K | -0.56% | +17.50% | |
| Form 10-Q Neurogene Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.28% | -1.22% | |
| Form 8-K Neurogene Inc. For: Aug 09 | SEC filing · Form 8-K | +0.00% | -1.69% | |
| Form 8-K Neurogene Inc. For: Aug 07 | SEC filing · Form 8-K | +0.00% | -4.35% | |
| Form 8-K Neurogene Inc. For: Jun 21 | SEC filing · Form 8-K | +0.00% | -0.93% | |
| Form 8-K Neurogene Inc. For: Jun 18 | SEC filing · Form 8-K | -0.10% | +0.61% | |
| Form 8-K Neurogene Inc. For: Jun 14 | SEC filing · Form 8-K | — | -1.28% | |
| Form 8-K Neurogene Inc. For: Jun 03 | SEC filing · Form 8-K | +0.03% | -2.03% | |
| Form 10-Q Neurogene Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -4.52% | |
| Form 8-K Neurogene Inc. For: May 10 | SEC filing · Form 8-K | +0.09% | -2.69% | |
| Form 8-K Neurogene Inc. For: May 07 | SEC filing · Form 8-K | +1.54% | +4.59% | |
| Form ARS Neurogene Inc. For: Dec 31 | SEC filing · Form ARS | +0.21% | -0.26% | |
| Form DEF 14A Neurogene Inc. For: Apr 26 | SEC filing · Form DEF | +0.21% | -0.26% | |
| Form DEFA14A Neurogene Inc. | SEC filing · Form DEFA14A | +0.21% | -0.26% | |
| Form 8-K Neurogene Inc. For: Apr 19 | SEC filing · Form 8-K | +0.62% | +2.68% | |
| Form 8-K Neurogene Inc. For: Apr 22 | SEC filing · Form 8-K | +0.00% | +1.53% | |
| Form 8-K Neurogene Inc. For: Apr 01 | SEC filing · Form 8-K | -0.81% | -1.01% | |
| Form 10-K Neurogene Inc. For: Dec 31 | SEC filing · Form 10-K | +1.22% | +12.93% | |
| Form 8-K Neurogene Inc. For: Mar 18 | SEC filing · Form 8-K | +1.22% | +12.93% | |
| Form 8-K Neurogene Inc. For: Mar 04 | SEC filing · Form 8-K | +0.00% | +17.50% | |
| Form 8-K Neurogene Inc. For: Feb 15 | SEC filing · Form 8-K | +0.17% | +0.30% | |
| Form S-8 Neurogene Inc. | SEC filing · Form S-8 | +0.00% | +1.02% | |
| Form SEC STAFF LETTER Neoleukin Therapeutics, | SEC filing · Form SEC | -0.01% | +1.42% | |
| Form 8-K Neurogene Inc. For: Jan 05 | SEC filing · Form 8-K | +4.82% | +10.39% |
Keep exploring
More NGNE: earnings → · analyst actions → · NGNE overview →